This is a federal contract award from the U.S. Department of Veterans Affairs (VA) to Pharmacy Buying Association, Inc. (PBA Health), a for-profit small business organization. The contract is for the delivery of pharmaceutical products, including Angragrelide HCL, Chlorzoxazone, Estradiol 0.1 mg, and Estradiol 0.0375 mg, to VA healthcare facilities. The contract has a firm fixed-price value of $100,407.58 and an ultimate completion date of April 14, 2017. PBA Health has an existing Indefinite Delivery Contract (IDC) with the VA Veterans Integrated Service Network 15, valued at $382,200, as well as a Federal Supply Schedule (FSS) contract with a $15.6 million ceiling, which allows the company to provide a comprehensive range of pharmaceutical and medical products to VA facilities nationwide. This contract award does not utilize a set-aside designation.